Journal article Open Access

Amiodarone – a rare cause of acute hepatitis – case presentation

Violeta Sapira; Anca Telehuz; Mihai Polinschi; Alexandru Nechifor; Valerica Zarnescu Creanga; Mihaela Lungu


MARC21 XML Export

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Intravenous amiodarone, acute hepatotoxicity, hepatic transaminases, amiodarone induced liver injury</subfield>
  </datafield>
  <controlfield tag="005">20200120170846.0</controlfield>
  <controlfield tag="001">3556828</controlfield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Slobozia Emergency County Hospital, Romania</subfield>
    <subfield code="a">Anca Telehuz</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, Romania</subfield>
    <subfield code="a">Mihai Polinschi</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, Romania</subfield>
    <subfield code="a">Alexandru Nechifor</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, Romania</subfield>
    <subfield code="a">Valerica Zarnescu Creanga</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Emergency Clinical County Hospital "Sfantul Apostol Andrei" Galati, "Dunarea de Jos" University of Galati</subfield>
    <subfield code="a">Mihaela Lungu</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">321713</subfield>
    <subfield code="z">md5:1d4e8fa232c190232ac70661511c5f00</subfield>
    <subfield code="u">https://zenodo.org/record/3556828/files/Sapira et al.pdf</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2019-11-28</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="p">openaire</subfield>
    <subfield code="o">oai:zenodo.org:3556828</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="u">Emergency Clinical County Hospital "Sfantul Apostol Andrei" Galati, "Dunarea de Jos" University of Galati</subfield>
    <subfield code="a">Violeta Sapira</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Amiodarone – a rare cause of acute hepatitis – case presentation</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u">https://creativecommons.org/licenses/by/4.0/legalcode</subfield>
    <subfield code="a">Creative Commons Attribution 4.0 International</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="a">cc-by</subfield>
    <subfield code="2">opendefinition.org</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">&lt;p&gt;&lt;strong&gt;Amiodarone, a Class III antiarrhythmic agent, used in the treatment of supraventricular and ventricular tachyarrhythmias, may cause acute hepatitis. Although it is a rare complication, it can be fatal. We presented the case of a 59-year-old patient without any personal pathological background, chronic medication and cardiovascular risk factors, who came in the emergency Department where he is diagnosed with atrial fibrillation. Intravenous amiodarone treatment is instituted, but at 12 hours after initiation of treatment, there is a significant increase in the level of hepatic transaminases. The diagnosis of acute hepatitis is made, possibly drug-related. After we stopped the amiodarone administration, the evolution is favorable, with the remission of the cytolysis syndrome. This case highlights the need for careful monitoring of patients receiving intravenous amiodarone to identify any potential for hepatotoxicity.&lt;/strong&gt;&lt;/p&gt;</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="n">doi</subfield>
    <subfield code="i">isVersionOf</subfield>
    <subfield code="a">10.5281/zenodo.3556827</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.5281/zenodo.3556828</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
</record>
59
49
views
downloads
All versions This version
Views 5959
Downloads 4949
Data volume 15.8 MB15.8 MB
Unique views 5454
Unique downloads 4848

Share

Cite as